Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerulonephritis, IGA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05065970
What this trial is testing

Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy

Who this might be right for
Immunoglobulin A (IgA) Nephropathy
HI-Bio, A Biogen Company 54
Testing effectiveness (Phase 2)Study completedNCT05016323
What this trial is testing

Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy.

Who this might be right for
IgA Nephropathy
Jiangsu HengRui Medicine Co., Ltd. 316
Not applicableStudy completedNCT01451710
What this trial is testing

The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy

Who this might be right for
IgA Nephropathy
Nanjing University School of Medicine 30
Not applicableUnknownNCT01773382
What this trial is testing

The Effects of Weight Reduction in IgA Nephropathy

Who this might be right for
Proteinuria
Chulalongkorn University 30
Not applicableStudy completedNCT01237028
What this trial is testing

Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers

Who this might be right for
IgA Nephropathy
Yonsei University 168
Post-approval studies (Phase 4)Study completedNCT04525729
What this trial is testing

Rituximab and RASi in Patients with IgAN

Who this might be right for
IgA Nephropathy
Nan Chen,MD 116
Not applicableStudy completedNCT01775527
What this trial is testing

IgA Nephropathy, Lymphocyte Homing and IgA Class Switch

Who this might be right for
IgA Nephropathy
University Hospital, Limoges 72
Testing effectiveness (Phase 2)Study completedNCT00396721
What this trial is testing

Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy

Who this might be right for
Glomerulonephritis, IGANephropathy, IGAIGA Nephropathy
Josep m Cruzado 23
Not applicableLooking for participantsNCT06952426
What this trial is testing

A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US

Who this might be right for
Immunoglobulin A Nephropathy
Novartis Pharmaceuticals 300
Not applicableNot Yet RecruitingNCT07649538
What this trial is testing

Mediators of Loin Pain in IgA Nephropathy

Who this might be right for
IgA Nephropathy (IgAN)
University of Leicester 40
Post-approval studies (Phase 4)UnknownNCT01184599
What this trial is testing

A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy

Who this might be right for
Glomerulonephritis, IGAHypertension
Kagawa University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06740526
What this trial is testing

Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue

Who this might be right for
IgA Nephropathy
Otsuka Pharmaceutical Development & Commercialization, Inc. 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07730632
What this trial is testing

Phase II Clinical Study on the Efficacy and Safety of QLS7305 in Patients With Kidney Disease (Part A)

Who this might be right for
IgAN - IgA NephropathyImmune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)C3 Glomerulopathy (C3G)+1 more
Qilu Pharmaceutical Co., Ltd. 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT05596708
What this trial is testing

Study of Telitacicept in Patients With Refractory IgA Nephropathy

Who this might be right for
IgA Nephropathy
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Testing effectiveness (Phase 2)Ended earlyNCT05125068
What this trial is testing

Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN)

Who this might be right for
IgA NephropathyIgAN
Eledon Pharmaceuticals 24
Not applicableStudy completedNCT01560052
What this trial is testing

Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)

Who this might be right for
IgA Glomerulonephritis
The George Institute 503
Post-approval studies (Phase 4)Study completedNCT01103778
What this trial is testing

Pilot Study of Velcade® in IgA Nephropathy

Who this might be right for
Chronic Kidney DiseaseIgA Nephropathy
The Rogosin Institute 11
Testing effectiveness (Phase 2)Looking for participantsNCT07616700
What this trial is testing

Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA Nephropathy

Who this might be right for
IgA Nephropathy (IgAN)
Haisco Pharmaceutical Group Co., Ltd. 73
Early research (Phase 1)Looking for participantsNCT07054684
What this trial is testing

Study of BHV-1400 in IgA Nephropathy

Who this might be right for
IgA Nephropathy
Biohaven Therapeutics Ltd. 20
Large-scale testing (Phase 3)Study completedNCT00870493
What this trial is testing

Aliskiren for Immunoglobulin A (IgA) Nephropathy

Who this might be right for
IgA Nephropathy
Chinese University of Hong Kong 22
Next Page